Chief Scientific Officer Alex van Belkum is a highly cited molecular microbiologist with extensive experience in molecular- and culture-based diagnostics, antimicrobial resistance testing and clinical microbiology. “I’m excited by how BaseClear can contribute further to developing solutions for global health challenges through data-rich technologies in clinical microbiology. The combination of Next Generation Sequencing technologies, culturomics and microbiome research has huge potential for the future,” he says.
Alex leads BaseClear’s science and innovation arm together with our Innovation Manager and a team of PhD-level Product Managers. “There are great opportunities for BaseClear to develop new and innovative solutions in areas such as human health, animal health and biomarker discovery. I’m working together with a excellent team of experienced and highly talented scientists within Innovation and Product Management. We have the knowledge to leverage microbial genomics technology to deliver valuable applications that will ultimately improve our quality of life,” he explains.
Alex van Belkum has many years of working experience in both industry and academia. He has worked for bioMérieux for over a decade, where he has held a number of scientific leadership roles including R&D director, Corporate Vice President Microbiology, CSO, and Scientific Director of the Data Analytics department. Prior to his work at bioMérieux, he was a staff member of the Institute of Clinical Microbiology and Antimicrobial Therapy, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam. He holds a double PhD in both biochemistry and molecular microbiology and is a former Professor of Molecular Microbiology at the Erasmus University Medical Center.